$1.25

+0.05 (+4.17%)

Weekly Expected Move ±16.8%

$1 $1 $1 $1 $2

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 43 · $9.8M mcap · 4M float · 0.131% daily turnover · Short 22% of daily vol

Revenue

$5M +12.5% ▲

Gross Profit

$4M +13.0% ▲

Operating Income

-$5M -1.3% ▼

Net Income

-$6M -17.3% ▼

EPS (Diluted)

$-0.86 -16.2% ▼

EBITDA

-$5M -17.9% ▼

View Full Income Statement

Line Item	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1M	$2M	$1M	$3M
Cost of Revenue	$228K	$256K	$281K	$526K
Gross Profit	$1M	$1M	$1M	$2M
Gross Margin	82.5%	84.5%	80.6%	79.6%
R&D Expenses	$0	$0	$0	$0
SG&A Expenses	$3M	$2M	$2M	$3M
Operating Expenses	$3M	$2M	$2M	$3M
Operating Income	-$2M	-$668K	-$878K	-$512K
Operating Margin	-158.6%	-40.4%	-60.7%	-19.8%
Interest Expense	$23K	$32K	$10K	$11K
Income Before Tax	-$2M	-$815K	-$852K	-$145K
Tax Expense	$0	$0	$0	$0
Net Income	-$2M	-$815K	-$852K	-$145K
Net Margin	-158.7%	-49.3%	-58.9%	-5.6%
EPS (Diluted)	$-0.32	$-0.12	$-0.12	$-0.02
EBITDA	-$2M	-$763K	-$823K	-$115K
Shares Outstanding	6M	6M	7M	8M

ZEOX OTC